Australia markets close in 3 hours 9 minutes

Silo Pharma, Inc. (SILO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1660-0.0090 (-5.14%)
At close: 3:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
153.931
40.923
40.569
0
847.407
Cost of revenue
245.155
176.126
27.387
-
-
Gross profit
-91.224
-135.203
13.182
-
-
Operating expenses
Research development
232.96
88.8
63.465
-
-
Selling general and administrative
2,458
2,184
864.18
459.83
313.371
Total operating expenses
2,691
2,272
927.645
459.83
490.871
Operating income or loss
-2,782
-2,408
-914.463
-459.83
-407.478
Interest expense
2.829
269.267
62.928
-
-
Total other income/expenses net
-36.87
-372.202
-48.099
-513.851
764.014
Income before tax
-2,816
-3,038
-1,013
-969.463
356.536
Income from continuing operations
-2,816
-3,038
-1,013
-969.463
356.536
Net income
-2,816
-3,038
-1,013
-969.463
356.536
Net income available to common shareholders
-4,220
-3,107
-1,013
-969.463
356.536
Basic EPS
-
-0.05
-0.04
-0.02
0.01
Diluted EPS
-
-0.05
-0.04
-0.02
0.01
Basic average shares
-
65,955
23,469
49,101
50,082
Diluted average shares
-
65,955
23,469
49,101
50,082
EBITDA
-
-2,768
-950.366
-442.28
-407.478